Orphenadrine injection
Products billed under this code include Orphenadrine Citrate Injection.
Payment limit per 60 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Orphenadrine Citrate Injection.
Payment limit per 60 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Orphenadrine Citrate Injection | Hikma Pharmaceuticals USA Inc. | 00641-6182-10 | 10 | $62.74 |
| Orphenadrine Citrate Injection | Hikma Pharmaceuticals USA Inc. | 00641-6182-25 | 25 | $156.85 |
| Orphenadrine Citrate Injection | Sagent Pharmaceuticals | 25021-0651-02 | 10 | $62.74 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $6.274 | −$1.503 | 60 MG | Orphenadrine injection | v1, posted September 17, 2026 |
| 3Q26 | $7.777 | −$0.441 | 60 MG | Orphenadrine injection | v1, posted September 15, 2026 |
| 2Q26 | $8.218 | +$1.828 | 60 MG | Orphenadrine injection | v1, posted September 15, 2026 |
| 1Q26 | $6.39 | −$4.796 | 60 MG | Orphenadrine injection | v1, posted September 15, 2026 |
| 4Q25 | $11.186 | +$1.738 | 60 MG | Orphenadrine injection | v1, posted September 8, 2026 |
| 3Q25 | $9.448 | −$2.88 | 60 MG | Orphenadrine injection | v1, posted March 10, 2026 |
| 2Q25 | $12.328 | −$1.666 | 60 MG | Orphenadrine injection | v1, posted March 10, 2026 |
| 1Q25 | $13.994 | +$5.209 | 60 MG | Orphenadrine injection | v1, posted December 19, 2025 |
| 4Q24 | $8.785 | −$0.308 | 60 MG | Orphenadrine injection | v1, posted June 11, 2025 |
| 3Q24 | $9.093 | −$0.027 | 60 MG | Orphenadrine injection | v1, posted June 11, 2025 |
| 2Q24 | $9.12 | −$0.585 | 60 MG | Orphenadrine injection | v1, posted March 11, 2025 |
| 1Q24 | $9.705 | +$5.033 | 60 MG | Orphenadrine injection | v1, posted December 19, 2024 |
| 4Q23 | $4.672 | −$11.864 | 60 MG | Orphenadrine injection | v1, posted October 10, 2024 |
| 3Q23 | $16.536 | +$11.158 | 60 MG | Orphenadrine injection | v1, posted June 5, 2024 |
| 2Q23 | $5.378 | +$1.088 | 60 MG | Orphenadrine injection | v1, posted February 23, 2024 |
| 1Q23 | $4.29 | +$0.217 | 60 MG | Orphenadrine injection | v1, posted December 6, 2023 |
| 4Q22 | $4.073 | −$0.042 | 60 MG | Orphenadrine injection | v1, posted June 22, 2023 |
| 3Q22 | $4.115 | −$0.501 | 60 MG | Orphenadrine injection | v1, posted June 9, 2023 |
| 2Q22 | $4.616 | −$0.571 | 60 MG | Orphenadrine injection | v1, posted December 14, 2022 |
| 1Q22 | $5.187 | −$0.734 | 60 MG | Orphenadrine injection | v1, posted June 8, 2022 |
| 4Q21 | $5.921 | +$0.189 | 60 MG | Orphenadrine injection | v1, posted June 2, 2022 |
| 3Q21 | $5.732 | −$0.207 | 60 MG | Orphenadrine injection | v1, posted June 2, 2022 |
| 2Q21 | $5.939 | −$0.894 | 60 MG | Orphenadrine injection | v1, posted March 1, 2022 |
| 1Q21 | $6.833 | – | 60 MG | Orphenadrine injection | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.